Keyword search
BIONOMICS LIMITED (BNO)

BIONOMICS LIMITED logo

Stock Code: BNO
Listing Date: 1999-12-21 00:00:00
Website: http://www.bionomics.com.au/
Industry: Pharmaceuticals, Biotechnology and Life Sciences

Principal Activities:
Developer of innovative treatments for cancer, mutiple sclerosis, anxiety and epilepsy.

Address:
31 Dalgleish Street
THEBARTON
SA    5031

Phone: 08 8354 6100
Fax: 08 8354 6199

Executives & Directors

Mr Chris Fullerton, Chairman
Dr Deborah Rathjen, Managing Director, CEO
Dr Errol De Souza, Non Exec. Director
Mr Trevor Tappenden, Non Exec. Director
Ms Melanie Young, CFO
Ms Melanie Young, Secretary

Company Podcasts

Subscribe to current and future audio events for this company by clicking on the podcast icon: Subscribe to BIONOMICS LIMITED Podcasts

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

 

Click here to view this company's details on the ASX site

Company Events Timezone: Icon_timezone Australia/Sydney
Company (Stock code) Date/time
Dates subject to change 		Event
Display audio events only
BIONOMICS LIMITED (BNO) Fri, 11 Nov 2011
9:45am 		Bionomics 2011 Annual General Meeting Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Wed, 9 Nov 2011 Annual General Meeting
BIONOMICS LIMITED (BNO) Fri, 4 Nov 2011
11:25am 		Bionomics Limited - ASX Small to Mid Caps Conference in Singapore and Hong Kong Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Thu, 6 Oct 2011
10:15am 		Bionomics to present at the ASX Small to Mid Caps conference in Hong Kong and Singapore Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Fri, 12 Aug 2011
11:30am 		Clinical trials reach key milestones for Bionomics Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Tue, 5 Apr 2011
2:00pm 		Bionomics Anti-Anxiety Drug Clinical Trials Successful Results - Dr Deborah Rathjen, Managing Director & CEO Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Fri, 11 Feb 2011 Interim Results
BIONOMICS LIMITED (BNO) Wed, 13 Oct 2010 Annual General Meeting
BIONOMICS LIMITED (BNO) Mon, 11 Oct 2010
11:00am 		BNC210 - European Approval Granted for Two Phase Ib Trials - Dr Deborah Rathjen, Managing Director Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Thu, 13 May 2010
10:30am 		Second BNC210 Phase 1 Clinical Trial Commences - Dr Deborah Rathjen, Managing Director & CEO Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Thu, 4 Feb 2010
12:30pm 		Bionomics Provides Update on BNC105 and BNC210 Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Fri, 6 Nov 2009
10:30am 		Bionomics Annual General Meeting Presentation - Deborah Rathjen, CEO and Managing Director Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Wed, 4 Nov 2009
3:00pm 		Annual General Meeting
BIONOMICS LIMITED (BNO) Fri, 9 Oct 2009
11:00am 		EGM
BIONOMICS LIMITED (BNO) Fri, 18 Sep 2009
10:00am 		Bionomics Investor Update, September 2009 - Deborah Rathjen, CEO and Managing Director Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Fri, 28 Aug 2009 Full Year Results
BIONOMICS LIMITED (BNO) Wed, 1 Jul 2009
11:00am 		BNO - Healthy Investment eConference - Dr Deborah Rathjen, CEO and Managing Director Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Wed, 3 Jun 2009
9:30am 		BNO - Anxiety Drug Candidate Approved to Enter Human Trial - Dr Deborah Rathjen, CEO and MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Tue, 3 Mar 2009
10:00am 		BNO - Half Yearly Report and Accounts - Dr Deborah Rathjen, CEO and MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Wed, 25 Feb 2009 Interim Results
BIONOMICS LIMITED (BNO) Tue, 11 Nov 2008
12:30pm 		BNO - 2008 Annual General Meeting - Dr Deborah Rathjen, CEO and MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Wed, 5 Nov 2008
11:00am
10:30am Australia/Adelaide 		Annual General Meeting
BIONOMICS LIMITED (BNO) Thu, 17 Jul 2008
3:00pm 		BNO - Company Update - Dr Deborah Rathjen, CEO and MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Thu, 21 Feb 2008
2:30pm 		BNO - 2008 Half Year Results - Dr Deborah Rathjen, CEO and MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Wed, 7 Nov 2007
11:00am 		BNO - 2007 Annual General Meeting - Dr Peter Jonson, Chairman and Dr Deborah Rathjen, CEO and MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Wed, 7 Nov 2007
10:30am 		Annual General Meeting
BIONOMICS LIMITED (BNO) Tue, 21 Aug 2007 Full Year Results
BIONOMICS LIMITED (BNO) Thu, 21 Jun 2007
2:15pm 		BNO - Bionomics Raises $10 Million in Private Placement - Dr Deborah Rathjen, CEO and MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Thu, 31 May 2007
2:30pm 		BNO - New Drug Candidate for Anxiety - Dr Deborah Rathjen, CEO and MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Mon, 26 Feb 2007 Interim Results
BIONOMICS LIMITED (BNO) Thu, 9 Nov 2006
2:30pm 		BNO - Annual General Meeting - Dr Deborah Rathjen, CEO & MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Thu, 9 Nov 2006
12:00pm 		Annual General Meeting
BIONOMICS LIMITED (BNO) Wed, 25 Oct 2006
3:30pm 		BNO - Contract with SAFC Pharma - Dr Deborah Rathjen, CEO & MD Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Tue, 22 Aug 2006 Full Year Results
BIONOMICS LIMITED (BNO) Tue, 27 Jun 2006
10:30am 		BNO - The New Bionomics - Dr Deborah Rathjen, CEO Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Fri, 28 Apr 2006
2:00pm 		BNO - Market Briefing - Dr Deborah Rathjen, CEO Dr Deborah Rathjen
BIONOMICS LIMITED (BNO) Tue, 14 Mar 2006 Interim Results
BIONOMICS LIMITED (BNO) Thu, 3 Nov 2005
10:30am
10:00am Australia/Adelaide 		Annual General Meeting